Publications

TitleAbstractYear(sorted ascending)
Filter
PMID
Filter
[australia antigen]. 19714944620
the australia antigen. 19714944667
[significance of australia antigen in the diagnosis and prevention of hepatitis]. 19714945211
[australia antigen and viral hepatitis]. 19714945214
[recent progress in the study of liver diseases]. 19714924536
[detection of the australia virus in blood transfusions]. 19714994099
hepatitis-associated antigen in liver disease in kenya. 19714992604
faecal s.h. (australia) antigen in acute hepatitis. 19714099874
australia antigen in familial cirrhosis. 19714099909
[australia antigen in hepatitis: technical and clinical aspects]. 19714338733
[detection of australia antigen by single radial diffusion method]. 19714333559
[primary cancer of the liver associated with australian antigen]. 19714333561
investigations of liver biopsies for australia antigen by immunofluorescent technique. 19714333813
[viral complications of renal transplantation]. 19714339632
[neurologic complications of liver diseases]. 19714256005
practical applications of the australia antigen test. 19714256842
a sex difference in the carrier state of australia (hepatitis-associated) antigen. 19714256915
[case studies on "au" antigen]. 19714261219
familial hepatoma with hepatitis-associated antigen. 19714324021
australia antigen: a genetic basis for chronic liver disease and hepatoma? 19714324024
infective hepatitis and the handling of specimens in general practice. 19714325135
hepatitis-associated antigen in urban children. 19714328650
hepatocellular carcinoma, positive australia (hepatitis-associated) antigen and sarcoidosis. 19714329070
seroepidemiological studies of transfusion-associated hepatitis. 19714329346
complement fixation test in the study of australia antigen. 19714329438
a simple procedure for preparation of antiserum to hepatitis-associated antigen by use of immune tolerance to serum proteins. 19714329934
hepatitis-associated antigen and hepatocellular carcinoma in taiwan. 19714330676
australia antigen and hepatitis in accra, ghana.viral hepatitis in young adults in accra, ghana, is associated with australia antigen (h.a.a.). sera from 85 patients in hospital with viral hepatitis were available for determinations of h.a.a. of the 16 patients whose serum was obtained within the first week of symptoms, 15 were positive. the only factor related to finding h.a.a. was the time between onset of symptoms and the collection of the serum sample. persistence of h.a.a. was associated with persistence of jaundice in men but not in wom ...19714330910
primary liver cell carcinoma and post-necrotic cirrhosis associated with australia antigen and alpha-feto protein. (a case report). 19714332064
[recent acquisitions in virological research]. 19714332188
[alpha 1 fetoglobulin in hapatoma]. 19714110121
hepatitis associated antigen: elimination from a dialysis unit and persistence in renal transplant recipients. 19714110165
detection of australia antigen in human tissue culture preparations. 19714257082
the epidemiology of serum hepatitis (sh) infections: a controlled study in two closed institutions. 19714257304
[current concepts of the australia antigen]. 19714257425
[radioimmunological determination of australia antigen]. 19714257440
[standardization of complement fixation methods for the detection of australia antigen]. 19714257441
[the australian antigen problem]. 19714257775
[au antigen: study in a group of mongoloid patients and in patients with viral hepatitis]. 19714258762
occurrence of australia antigen in patients with down's syndrome in poland. 19714253115
a review of the present position of australia antigen. 19714254352
[australia-sh antigen and virus hepatitis]. 19714255020
[incidence and occurrence of down's syndrome in csr in the years 1961-1966]. 19714255390
relative sensitivity of gel diffusion, complement fixation, and immunoelectroosmophoresis tests for detection of hepatitis-associated antigen and antibody.the immunoelectroosmophoresis (ieop) test was compared with gel diffusion and complement fixation (cf) tests for sensitivity in detecting hepatitis-associated antigen (haa) in the sera of hepatitis patients, for titration of haa, and for detection of antibody to haa. the ieop test was found to be slightly more sensitive than either gel diffusion or cf tests for detection of antigen in the patients' sera. titers of haa demonstrated by ieop were higher than those seen in gel diffusion tests but lo ...19714255416
thyroid antibodies and australia antigen in down's syndrome. 19714255524
australia antigen and antibody and alpha-fetoglobulin in hepatoma patients. 19714109107
improved technique for detecting australia antigen by immunoelectroosmophoresis. 19714109667
total screening of blood donations for h.a.a. and anti-h.a.a. 19714099230
antibodies against australiantigen in laboratory personnel. 19714099231
crossover electrophoresis for the rapid detection of serum hepatitis (australia) antigen and antibody. 19714252277
serum hepatitis antigen (sh) carrier state: relation to abo blood groups.in a comparison of 347 chronic carriers of the sh antigen and 8,864 controls with respect to abo and rh blood group distribution no significant differences have been detected.19714252612
inflammatory effect of au-antibody immune complexes. 19714100931
h. a. a. and a. n. a. in chronic active hepatitis. 19714100932
is the urine infective in serum hepatitis? 19714101289
absence of au antigen in faeces of patients with au-positive sera. 19714101290
the australia antigen in chronic active hepatitis. 19714101502
detecting h.a.a. in small quaniities. 19714101639
possible absence of australia antigen in g-g translocation-type down's syndrome. 19714101640
blood-groups, australia (au-s.h.) antigen, and viral hepatitis. 19714102044
student outbreak of hepatitis in argentina. 19714102045
s.h. antigen in bile. 19714102046
distinctions in chronic active eepatitis based on circulating h.a.a. 19714102202
laboratory tests for h.a.a. 19714102203
transmutation of au. 19714102204
au-h.a.a. in sera of diabetic patients. 19714102232
lupoid hepatitis and h.a.a. 19714102424
search for australia-s.h. antigen and antibody after a norwegian hepatitis outbreak. 19714102425
australia antigen and antibody in 10,000 danish blood-donors. 19714102548
sensitive matrix gel diffusion test for the detection of australia antigen.a matrix gel diffusion (mgd) procedure with a sensitivity comparable to the complement fixation test (cf) has been developed for detecting australia antigen in serum. the test utilizes a thin layer of agar (0.1 mm) with an applied plastic matrix. reactants are introduced directly onto the surface of the agar through wells in the plastic matrix. end points obtained by cf with a panel of 11 sera varied from 1:8 to 1:512. when these sera were tested by mgd, end points for detection of antigen were ...19714102574
d.n.a. polymerase in preparations containing australia antigen. 19714102625
polymerase in australia-antigen preparations. 19714102632
australia antigen in singapore chinese patients with hepatocellular carcinoma. 19714102859
primary carcinoma of the liver associated with australia antigen. 19714102879
australia antigen and smooth-muscle antibody in chronic active hepatitis. 19714102880
frequency of australia antigen in patients with leukaemia in different countries. 19714103075
role of immune complexes involving sh antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. 19714103392
relationship of hepatitis-associated antigen (h.a.a.) to acute and chronic liver injury. 19714103666
chronic active hepatitis with features of primary biliary cirrhosis. 19714103756
australia antigen: grouping the subsets. 19714103794
virus-like particles in cytoplasm of livers of au-antigen carriers. 19714103995
specificity of au antibodies. 19714103996
[study of virus-like particles and various ultrastructural lesions in severe viral hepatitis. relation with australia antigen]. 19714104104
australia antigen and antibody in 14,379 volunteer blood-donors from s.r. machedonia. 19714104489
australia antigen in urine. 19714104722
hepatitis-associated antigen in hospital patients. 19714104757
australia antigen in turkey. 19714104758
glomerulonephritis with deposition of australia antigen-antibody complexes in glomerular basement membrane. 19714104770
australia antigen, coronavirus, and reverse transcriptase in viral hepatitis. 19714104794
relationship of h.a.a. to acute and chronic liver injury. 19714104874
hepatitis and arthritis with hepatitis-associated antigen in serum and synovial fluid. 19714104875
hepatitis-associated antigen and hepatocellular carcinoma. 19714104876
australia antigen and down's syndrome. 19714104877
occurrence of australia antigen in patients with leukaemia in canada. 19714105072
do the hepatitis antigens cross the placenta? 19714105073
confirmatory tests for au antigen. 19714105074
management of the asymptomatic carrier of the hepatitis-associated (australia antigen. tentative considerations of the clinical and public-health aspects. 19714105091
h.a.a. in drug addicts. 19714105201
detection of bound hepatitis-associated antigen. 19714105203
possible transplacental transmission of serum hepatitis. 19714105204
changes induced by hepatitis serum in cultured liver cells. 19714105293
Displaying items 501 - 600 of 44607